Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2025-12-26 @ 3:30 AM
Study NCT ID:
NCT00416520
Status:
COMPLETED
Last Update Posted:
2014-11-04
First Post:
2006-12-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia
Sponsor:
Tanabe Pharma Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2009-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-27
First Submit QC Date:
None
Study First Post Date:
2006-12-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-08-22
Results First Submit QC Date:
None
Results First Post Date:
2014-10-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-28
Last Update Post Date:
2014-11-04
Last Update Post Date Type:
ESTIMATED